Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review

被引:7
|
作者
He, Weixiang [1 ]
Ding, Ting [2 ]
Niu, Zhiping [3 ]
Hao, Chunlin [1 ]
Li, Chengbin [1 ]
Xu, Zhicheng [1 ]
Jing, Yuming [1 ]
Qin, Weijun [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Lab Med, Xian, Shaanxi, Peoples R China
[3] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
基金
中国国家自然科学基金;
关键词
benign prostate hyperplasia; lower urinary tract symptoms; surgery; retreatment; reoperation; HOLMIUM LASER ENUCLEATION; TERM-FOLLOW-UP; RANDOMIZED CONTROLLED-TRIAL; STANDARD TRANSURETHRAL RESECTION; TITANYL-PHOSPHATE LASER; URINARY-TRACT SYMPTOMS; PHOTOSELECTIVE VAPORIZATION PROSTATECTOMY; BLADDER OUTLET OBSTRUCTION; TRANSVESICAL PROSTATECTOMY; PLASMAKINETIC ENUCLEATION;
D O I
10.3389/fendo.2023.1287212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Surgical treatment is important for male lower urinary tract symptom (LUTS) management, but there are few reviews of the risks of reoperation.Objective To systematically evaluate the current evidence regarding the reoperation rates of surgical treatment for LUTS in accordance with current recommendations and guidelines.Evidence acquisition Eligible studies published up to July 2023, were searched for in the PubMed (R) (National Library of Medicine, Bethesda, MD, USA), Embase (R) (Elsevier, Amsterdam, the Netherlands), and Web of Science (TM) (Clarivate (TM), Philadelphia, PA, USA) databases. STATA (R) (StataCorp LP, College Station, TX, USA) software was used to conduct the meta-analysis. Random-effects models were used to calculate the pooled incidences (PIs) of reoperation and the 95% confidence intervals (CIs).Evidence synthesis A total of 119 studies with 130,106 patients were included. The reoperation rate of transurethral resection of the prostate (TURP) at 1, 2, 3, and 5 years was 4.0%, 5.0%, 6.0%, and 7.7%, respectively. The reoperation rate of plasma kinetic loop resection of the prostate (PKRP) at 1, 2, 3, and 5 years was 3.5%, 3.6%, 5.7%, and 6.6%, respectively. The reoperation rate of holmium laser enucleation of the prostate (HoLEP) at 1, 2, 3, and 5 years was 2.4%, 3.3%, 5.4%, and 6.6%, respectively. The reoperation rate of photoselective vaporization of the prostate (PVP) at 1, 2, 3, and 5 years was 3.3%, 4.1%, 6.7%, and 7.1%, respectively. The reoperation rate of surgery with AquaBeam (R) at 1, 2, 3, and 5 years was 2.6%, 3.1%, 3.0%, and 4.1%, respectively. The reoperation rate of prostatic artery embolization (PAE) at 1, 2, 3, and 5 years was 12.2%, 20.0%, 26.4%, and 23.8%, respectively. The reoperation rate of transurethral microwave thermotherapy (TUMT) at 1, 2, 3, and 5 years was 9.9%, 19.9%, 23.3%, and 31.2%, respectively. The reoperation rate of transurethral incision of the prostate (TUIP) at 5 years was 13.4%. The reoperation rate of open prostatectomy (OP) at 1 and 5 years was 1.3% and 4.4%, respectively. The reoperation rate of thulium laser enucleation of the prostate (ThuLEP) at 1, 2, and 5 years was 3.7%, 7.7%, and 8.4%, respectively.Conclusion Our results summarized the reoperation rates of 10 surgical procedures over follow-up durations of 1, 2, 3, and 5 years, which could provide reference for urologists and LUTS patients.Systematic review registration https://www.crd.york.ac.uk/PROSPERO, identifier CRD42023445780.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Emerging drugs for the treatment of benign prostatic hyperplasia
    Thomas, Dominique
    Chughtai, Bilal
    Kini, Mitali
    Te, Alexis
    EXPERT OPINION ON EMERGING DRUGS, 2017, 22 (03) : 201 - 212
  • [22] Recent advances in the surgical treatment of benign prostatic hyperplasia
    Rocco, Bernardo
    Albo, Giancarlo
    Ferreira, Rafael Coelho
    Spinelli, Matteo
    Cozzi, Gabriele
    Dell'Orto, Paolo
    Patel, Vipul
    Rocco, Francesco
    THERAPEUTIC ADVANCES IN UROLOGY, 2011, 3 (06) : 263 - 272
  • [23] Surgical Complications in the Management of Benign Prostatic Hyperplasia Treatment
    Ottaiano, Nicholas
    Shelton, Thomas
    Sanekommu, Ganesh
    Benson, Cooper R.
    CURRENT UROLOGY REPORTS, 2022, 23 (05) : 83 - 92
  • [24] Impact of Surgery for Benign Prostatic Hyperplasia on Sexual Function: A Systematic Review and Meta-analysis of Erectile Function and Ejaculatory Function
    Manfredi, Celeste
    Garcia-Gomez, Borja
    Arcaniolo, Davide
    Garcia-Rojo, Esther
    Crocerossa, Fabio
    Autorino, Riccardo
    Gratzke, Christian
    De Sio, Marco
    Romero-Otero, Javier
    EUROPEAN UROLOGY FOCUS, 2022, 8 (06): : 1711 - 1732
  • [25] Advances in Outpatient Therapies and Treatment of Benign Prostatic Hyperplasia A Comprehensive Review for Men's Health
    Helman, Talia A.
    Browne, Brendan M.
    MEDICAL CLINICS OF NORTH AMERICA, 2024, 108 (05) : 981 - 991
  • [26] Holmium laser for the surgical treatment of benign prostatic hyperplasia
    Thurmond, Portia
    Bose, Sanchita
    Lerner, Lori B.
    CANADIAN JOURNAL OF UROLOGY, 2016, 23 (04) : 8356 - 8362
  • [27] Acupuncture for benign prostatic hyperplasia: a systematic review protocol
    Zhang, Wei
    Yu, Jinna
    Liu, Zhishun
    Peng, Weina
    BMJ OPEN, 2015, 5 (04):
  • [28] Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review
    Teoh, Jeremy Y. C.
    Chiu, Peter K. F.
    Yee, Chi-Hang
    Wong, Hon-Ming
    Chan, Chi-Kwok
    Chan, Eddie S. Y.
    Hou, Simon S. M.
    Ng, Chi-Fai
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (02) : 197 - 203
  • [29] Benign prostatic hyperplasia medical treatment: Systematic review of the literature by the CTMH/AFU
    Robert, G.
    Descazeaud, A.
    Delongchamps, N. Barry
    Cornu, J-N
    Azzouzi, A. R.
    Haillot, O.
    Devonec, M.
    Fourmarier, M.
    Ballereau, C.
    Lukacs, B.
    Dumonceau, O.
    Saussine, C.
    de la Taille, A.
    PROGRES EN UROLOGIE, 2012, 22 (01): : 7 - 12
  • [30] HoLEP: the new gold standard for surgical treatment of benign prostatic hyperplasia
    Shvero, Asaf
    Calio, Brian
    Humphreys, Mitchell R.
    Das, Akhil K.
    CANADIAN JOURNAL OF UROLOGY, 2021, 28 : 6 - 10